Defunct Company
Total Trials
18
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,060
NCT01696565
PG2 Phase I/II Clinical Study Intravenously Administered in Patients With Advanced Malignancy
Phase: Phase 1/2
Role: Lead Sponsor
Start: Dec 31, 2001
Completion: Oct 31, 2003
NCT00523107
PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care
Phase: Phase 2/3
Start: Aug 31, 2007
Completion: Apr 30, 2008
NCT00518869
Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue
Start: Sep 30, 2007
Completion: Dec 31, 2009
NCT00547846
A Phase II Clinical Study of PDC-748 in Patients With Acute Cough
Phase: Phase 2
Start: Oct 31, 2007
Completion: Not specified
NCT00693667
Study of PH3 for the Prevention of Osteoporosis in Postmenopausal Women
Start: Feb 29, 2008
Completion: Jul 31, 2011
NCT00861549
Bioavailability, Pharmacokinetics and Safety Evaluation of Phencynonate Hydrochloride in Healthy Volunteers
Phase: Phase 1
Start: Aug 31, 2008
Completion: Jan 31, 2010
NCT00860600
Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients
Start: Sep 30, 2008
Completion: Aug 31, 2011
NCT01052090
Safety and Efficacy Study in Hepatitis C Patients With PHN121
Start: Sep 30, 2009
Completion: Dec 31, 2013
NCT01068041
Effects of PH3 in Diabetic Nephropathy
Start: Aug 31, 2010
Completion: Sep 30, 2015
NCT01325233
The Pilot Clinical Study of PG2 Injection on Hemorrhagic Stroke
Phase: Early Phase 1
Start: Mar 31, 2011
Completion: Sep 30, 2013
NCT02192151
Study of PHN131 in Healthy Volunteers
Phase: N/A
Start: Oct 31, 2011
Completion: Oct 31, 2012
NCT01720550
Phase: Phase 4
Start: Nov 30, 2012
Completion: Jun 30, 2017
NCT01720563
A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy
Start: Dec 31, 2012
Completion: Apr 30, 2014
NCT02193620
Study of PHN131 in Patients After Surgery
Start: Apr 30, 2013
Completion: Feb 13, 2019
NCT02077621
Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer
Start: Feb 28, 2014
Completion: Dec 31, 2020
NCT03314805
PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy
Start: Mar 1, 2018
Completion: Aug 27, 2021
NCT03611712
PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer
Start: Feb 19, 2019
Completion: Mar 5, 2025
NCT05440227
PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients
Start: May 17, 2023
Completion: Jun 30, 2026